Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Human Life CORD is a clinical-stage Japanese biotechnology company that develops off-the-shelf umbilical cord-derived allogeneic cell therapies. Its pipeline includes genetically unmodified mesenchymal stromal cell products intended to treat a range of indications from incurable disorders to aging-related diseases. The company focuses on using domestically sourced umbilical cord tissue to scale manufacturing, ensure quality and availability, and advance the next evolution of cellular medicine for an aging population.